Article

Metabolic characterization of aggressive breast cancer cells exhibiting invasive phenotype: Impact of non-cytotoxic doses of 2-DG on diminishing invasiveness

2020-09-14

Abstract excerpt

<h4>Background: </h4> Metabolic reprogramming is being recognized as a fundamental hallmark of cancer, and efforts to identify drugs that can target cancer metabolism are underway. In this study, we used human breast cancer (BC) cell lines and established their invading phenotype (INV) collected from transwell inserts to compare metabolome differences and evaluate prognostic significance of the metabolome in aggre...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 0a18d840-5df6-5dfe-bdf9-f3e20f347d52
DOI: 10.21203/rs.3.rs-36631/v3

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Metabolic characterization of aggressive breast cancer cells exhibiting invasive phenotype: Impact of non-cytotoxic doses of 2-DG on diminishing invasivenessDOI 10.21203/rs.3.rs-36631/v3Read

Metabolic characterization of aggressive breast cancer cells exhibiting invasive phenotype: impact of non-cytotoxic doses of 2-DG on diminishing invasivenessSemantic proximity Read

Integrated Metabolic and Gene Expression Profiling Reveals New Therapeutic Modalities for Rapidly Proliferating Breast CancersSemantic proximity Read

2-Deoxy-D-Glucose inhibits aggressive triple-negative breast cancer cells by targeting glycolysis and the cancer stem cell phenotypeSemantic proximity Read

Metabolic reprogramming supports the invasive phenotype in malignant melanoma.Semantic proximity Read

Metabolic interaction between cancer cells and stromal cells according to breast cancer molecular subtype.Semantic proximity Read

Altered gene expression in glycolysis-cholesterol synthesis axis correlates with outcome of triple-negative breast cancer.Semantic proximity Read

Metabolomic and Mitochondrial Fingerprinting of the Epithelial-to-Mesenchymal Transition (EMT) in Non-Tumorigenic and Tumorigenic Human Breast CellsSemantic proximity Read

Metabolomics, Transcriptomics and Functional Glycomics Reveals Bladder Cancer Cells Plasticity and Enhanced Aggressiveness Facing Hypoxia and Glucose DeprivationSemantic proximity Read

Metabolic reprogramming in breast cancer results in distinct mitochondrial bioenergetics between luminal and basal subtypesSemantic proximity Read

miR-526b dysregulates glucose metabolism via the COX2/EP4 pathwaySemantic proximity Read

Bulk and single-cell transcriptome profiling reveal the metabolic heterogeneity in human breast cancersSemantic proximity Read

Glucose addiction in cancer therapy: advances and drawbacksSemantic proximity Read